The effect of TCA (20%) trichloroacetic acid and topical combination of steroid and tretinoin in macular amyloidosis

Comparison of the effect of TCA (20%) trichloroacetic acid and topical combination of steroid and tretinoin in macular amyloidosis; a double blind clinical trial.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180102038188N1

Enrollment

Registered

2018-06-13

Start date

2018-06-05

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular amyloidosis.

Interventions

Intervention 1: Intervention group: Given that the disease is a sympathetic disease, on one side of the body, TCA 20% will be used. This intervention will be done for three one month periods. Interven

Eligibility

Sex/Gender

All

Age

25 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients with macular amyloidosis referring to dermatology clinic of Sabzevar Vasei Hospital Being at the age of 25 to 45 years Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cutaneous pigmentation. Timepoint: 0, 1, 2 and 3 months later. Method of measurement: Checklist completed by dermatologist.	—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Karabi

Sabzevar University of Medical Sciences

arezomande90@medsab.ac.ir+98 21 4401 8317

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026